Prediction of long-term kidney failure in renal transplant with chronic allograft dysfunction using stage-specific hazard rates

Experimental and Clinical Transplantation

Volumn 10, Issue 1, 2012, Pages 8-13

  Khalkhali, Hamid Reza ^a   Ghafari, Ali ^b  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

5 stage model; Graft survival; Markov model; Phase type distribution; Survival analysis

Indexed keywords

ADULT; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; DISEASE COURSE; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HUMAN; IRAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PREDICTION; PROBABILITY; RETROSPECTIVE STUDY; STAGE SPECIFIC HAZARD RATE; STAGING; STATISTICAL ANALYSIS;

DISEASE PROGRESSION; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HUMANS; IRAN; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84856869851     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.2011.0049     Document Type: Article

References (39)

1. World Kidney Day March 10, 2011 Web site. National Kidney and Transplant Institute Web site. http://www.worldkidneyday.org: Accessed November 18, 2011.
2. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285-1295.
3. Shlipak MG, Fried LF, Stehman-Breen C, Siscovick D, Newman AB. Chronic renal insufficiency and cardiovascular events in the elderly: findings from the Cardiovascular Health Study. Am J Geriatr Cardiol. 2004;13(2):81-90.
4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-1305.
5. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant. 2004;4(3):378-383.
6. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant. 2004;4(8):1289-1295.
7. Sayegh MH, Carpenter CB. Transplantation 50 years later-progress, challenges, and promises. N Engl J Med. 2004;351(26):2761-2766.
8. Keith DS, DeMattos A, Golconda M, et al. Factors associated with improvement in deceased donor renal allograft function in the 1990s. J Am Soc Nephrol. 2005;16(5):1512-1521.
9. Longini IM Jr, Clark WS, Byers RH, et al. Statistical analysis of the stages of HIV infection using a Markov model. Stat Med. 1989;8 (7):831-843.
10. Gentleman RC, Lawless JF, Lindsey JC, Yan P. Multi-state Markov models for analyzing incomplete disease history data with illustrations for HIV disease. Stat Med. 1994;13(3):805-821.
11. Brookmeyer R, Liao J. Statistical modeling of the AIDS epidemic for forecasting health care needs. Biometrics. 1990;46(4):1151-1163.
12. Aalen OO, Farewell VT, De Angelis D, Day NE, Gill ON. A Markov model for HIV disease progression including the effect of HIV diagnosis and treatment: application to AIDS prediction in England and Wales. Stat Med. 1997;16(19):2191-2210.
13. Escolano S, Golmard JL, Korinek AM, Mallet A. A multi-state model for evolution of intensive care unit patient: prediction of nosocomial infections and deaths. Stat Med. 2000;19(24):3465-3482.
14. Hansen BE, Thorogood J, Hermans J, Ploeg RJ, Van Bockel JH, Van Houwelingen JC. Multistate modeling of liver transplantation data. Stat Med. 1994;13(23-24):2517-2529.
15. Andersen PK. Multistate models in survival analysis: a study of nephropathy and mortality in diabetes. Stat Med. 1988;7:661-670.
16. Satten GA, Datta S. Marginal estimation for multi-stage models: waiting time distributions and competing risks analysis. Stat Med. 2002;21(1):3-19.
17. Marshall G, Jones RH. Multi-state models and diabetic retinopathy. Stat Med. 1995;14(18):1975-1983.
18. Yau CL, Huzerbazar AV. Analysis of censored and incomplete survival data using flowgraph models. Stat Med. 2002;21:3727-3743.
19. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med. 2002;347(2):103-109.
20. Chapman JR, O'Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol. 2005;16(10):3015-3026.
21. Paul LC. Chronic allograft nephropathy: an update. Kidney Int. 1999;56(3):783-793.
22. Cockcrorft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.
23. Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification: Part 4. Definition and classification of stages of chronic kidney disease. Am J Kidney Dis. 2002;39(2):S46-S75.
24. Aalen OO, Borgan O, Gjessing K. Survival and Event History Analysis: A Process Point of View. Springer Science+Business Media; 2008.
25. Djamali A, Kendziorski C, Brazy PC, Becker BN. Disease progression and outcomes in chronic kidney disease and renal transplantation. Kidney Int. 2003;64(5):1800-1807.
26. Gill JS, Tonelli M, Mix CH, Pereita BJG. The change in allograft functions among long-term kidney transplant recipients. J Am Soc Nephrol. 2003;14(6):1636-1642.
27. Gourishankar S, Hunsicker LG, Jhangri GS, Cockfield SM, Halloran PF. The stability of the glomerular filtration rate after renal transplantation is improving, J Am Soc Nephrol. 2003;14(9):2387-2394.
28. Kukla A, Adulla M, Pascual J, et al. CKD stage-to-stage progression in native and transplant kidney disease. Nephrol Dial Transplant. 2008;23(2):693-700.
29. Sijpkens YWJ, Zwinderman AH, Mallat MJK, Boom H, Fijter JWD, Leendert PC. Intercept and slope analysis of risk factors in chronic renal allograft nephropathy. Graft. 2002;5(2):108-113.
30. Faddy M J, Taylor GJ. Stochastic modeling of the onset of bronchiolitis obliterans syndrome after lung transplantation: an analysis of risk factors, mathematical and computer modeling. Mathematical and Computer Modelling. 2003;38(11-13):1185-1189.
31. Weijnen TJ, van Hamersvelt HW, Just PM, et al. Economic impact of extended time on peritoneal dialysis as a result of using polyglucose: the application of a Markov chain model to forecast changes in the development of the ESRD programme over time. Nephrol Dial Transplant. 2003;18(2):390-396.
32. Littlewood KJ, Greiner W, Baum D, Zoellner Y. Adjunctive treatment with moxonidine versus nitrendipine for hypertensive patients with advanced renal failure: a cost-effectiveness analysis. BMC Nephrol. 2007;8:9.
33. Hui-Min W, Ming-Fang Y, Chen TH. SAS macro program for nonhomogeneous Markov process in modeling multi-state disease progression. Comput Methods Programs Biomed. 2004;75(2):95-105.
34. Maindonald J, Braun WJ. Data Analysis and Graphics Using R: An Example-Based Approach. Cambridge, England: Cambridge University Press; 2003.
35. Neuts MF. Probability distributions of phase-type. In: Liber amicorum Prof. Emeritus H. Florin, ed. Chap Matrix-Geometric Solutions in Stochastic Models, Department of Mathematics, University of Louvain, Louvain, France; 1975.
36. Bladt M, Neuts MF. Matrix-exponential distributions: calculus and interpretations va flow. Commun Stat Stochastic Models. 2003;19(3):115-129.
37. Akaike H. A new look at the statistical model identification. IEEE Trans Automatic Control. 1974;19:716-723.
38. Brenner BM. Brenner and Rector's The Kidney. 8th ed. New York, NY: Saunders; 2008.
39. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342(9):605-612.